Name: Phototherapy Equipment Market by Product (Conventional Phototherapy Equipment, Fiber-Optic Phototherapy Equipment), Application (Neonatal Jaundice, Skin Diseases (Psoriasis, Vitiligo)), End User (Hospitals, Homecare Settings) - Global Forecast to 2031
Brand: MarketsandMarkets
SKU: MD4668
Price: 4950 USD
Availability: InStock

報告摘要

The phototherapy equipment market is projected to reach USD 0.62 billion by 2031, up from USD 0.47 billion in 2026, at a CAGR of 5.5%. Continuous technological innovation, particularly the transition from conventional fluorescent and halogen light sources to LED-based phototherapy systems, is significantly driving market growth. LED phototherapy devices offer multiple advantages, including higher energy efficiency, longer operational lifespan, reduced heat emission, and precise wavelength targeting, which enhances treatment effectiveness while minimizing risks. These systems also provide uniform light distribution, improving clinical outcomes in both neonatal and dermatological applications. Additionally, advancements in device design have led to the development of compact, user-friendly, and low-maintenance systems, making them more accessible to healthcare facilities with varying resource levels. Manufacturers are also integrating smart features such as digital displays, intensity controls, and automated timers, which improve usability and treatment accuracy. The growing preference for technologically advanced solutions among healthcare providers is accelerating the replacement of older equipment with modern LED-based systems. This ongoing innovation cycle not only improves patient outcomes but also creates a steady global demand for upgraded phototherapy equipment. Based on product: One of the most significant drivers of the dominance of conventional phototherapy equipment is its cost advantage over advanced alternatives, such as LED-based and fiber-optic systems. Conventional units typically have lower upfront acquisition costs, making them highly attractive for hospitals operating under tight budget constraints. In addition to capital expenditure, these systems also incur lower maintenance and servicing costs due to their simpler design and readily available components. This affordability becomes particularly crucial in price-sensitive markets, where healthcare providers must balance quality care with financial limitations. Public hospitals, small clinics, and rural healthcare centers often prioritize cost-effective solutions that can deliver acceptable clinical outcomes without significant investment. Moreover, large-scale procurement programs, especially in government-funded healthcare systems, tend to favor conventional equipment due to its economic viability. This strong cost-benefit equation ensures that conventional phototherapy remains widely accessible and continues to dominate market demand despite the availability of technologically advanced alternatives. Based on application: Phototherapy is universally recognized as the first-line treatment for neonatal hyperbilirubinemia due to its proven safety, efficacy, and non-invasive nature. It works by converting bilirubin into water-soluble isomers that can be excreted without requiring liver conjugation. Clinical guidelines across major health organizations strongly recommend phototherapy as the initial intervention before considering more invasive procedures such as exchange transfusion. This strong clinical endorsement ensures that phototherapy devices are routinely used in hospitals, particularly in NICUs and maternity centers. The treatment is easy to administer, requires minimal training, and has a low risk of adverse effects, making it suitable for widespread use even in resource-limited settings. Additionally, advancements such as LED-based phototherapy systems have further improved treatment efficiency and reduced operational costs, reinforcing its position as the preferred treatment modality. As a result, healthcare providers consistently rely on phototherapy equipment, which drives its dominant share in the neonatal jaundice segment. North America’s well-developed healthcare infrastructure plays a crucial role in supporting the widespread adoption of phototherapy equipment. The region boasts an extensive network of hospitals, specialty clinics, and advanced neonatal care facilities, all equipped to diagnose and treat neonatal and dermatological conditions efficiently. Healthcare systems in the US and Canada are characterized by strong clinical protocols, modern medical technologies, and highly trained professionals, enabling seamless integration of phototherapy solutions into routine care. Additionally, the availability of well-equipped neonatal intensive care units ensures that even high-risk infants receive immediate treatment. This infrastructure not only facilitates access to phototherapy but also encourages healthcare providers to invest in technologically advanced systems such as LED-based devices. Furthermore, regular upgrades and maintenance of medical equipment, driven by stringent quality standards, contribute to sustained demand. The presence of such a robust healthcare ecosystem ensures consistent utilization and adoption of phototherapy devices across multiple care settings. A breakdown of the primary participants (supply-side) for the phototherapy equipment market referred to in this report is provided below: • By Company Type: Tier 1:34%, Tier 2: 38%, and Tier 3: 28% • By Designation: C-level: 26%, Director Level: 35%, and Others: 39% • By Region: North America: 17%, Europe: 39%, Asia Pacific: 28%, Latin America: 8%, Middle East & Africa: 3%, GCC Countries: 5% Prominent players in the phototherapy equipment market are market Drägerwerk AG & Co. KGaA (Germany), GE HealthCare (US), Natus Medical (US), Atom Medical (Japan), Bistos (South Korea), Ningbo David (China), Phothera (US), STRATA Skin Sciences (US), Xuzhou Kernel Medical (China), Shanghai SIGMA High-tech (China), Ultralite Enterprises, Inc. (US), Hoenle Medical GmbH (Germany), Weyer (Germany), Neolight (US), Fanem (Brazil), Phoenix Medical Systems (India), among others. Research Coverage The report evaluates the phototherapy equipment market and estimates the market size and future growth potential of this market based on various segments, including product, application, end user, and region. The report also includes a competitive analysis of the major players in this market, along with company profiles, product offerings, recent developments, and key market strategies. Reasons to Buy the Report The report will assist the market leader and new entrants with data on the nearest approximations of revenue for the overall market, the phototherapy equipment market, and its subsegments. The report will assist stakeholders in understanding the competitive landscape and in gaining further insights to better position their businesses and develop appropriate go-to-market strategies. The report assists the stakeholders in understanding the market pulse and gives them data on influential drivers, hindrances, obstacles, and opportunities in the market. This report provides insights into the following points:  Analysis of key drivers (rising incidence of neonatal jaundice, rising number of preterm and low-weight births, rising prevalence of skin diseases, launch of technologically advanced phototherapy equipment, rising adoption of LED-based phototherapy equipment), restraints (high use of alternative modes of treatment, stringent FDA regulatory policies for the approval of new devices), opportunities (development of low-cost phototherapy equipment, rising adoption of home phototherapy for the treatment of skin diseases), and challenges (rising trend of purchasing refurbished phototherapy equipment in emerging markets, limited adoption of phototherapy equipment in developing nations) • Product Enhancement/Innovation: Comprehensive details about product launches and anticipated trends in the global phototherapy equipment market • Market Development: Thorough knowledge and analysis of the profitable rising markets by product, application, end user, and region. • Market Diversification: Comprehensive information about newly launched products, expanding markets, current advancements, and investments in the global phototherapy equipment market • Competitive Assessment: Thorough evaluation of the market shares, growth plans, offerings, and capacities of the major competitors in the global phototherapy equipment market

目錄 Table of Contents

1 INTRODUCTION 23 1.1 STUDY OBJECTIVES 23 1.2 MARKET DEFINITION 23 1.3 STUDY SCOPE 24 1.3.1 MARKETS COVERED 24 1.3.2 INCLUSIONS & EXCLUSIONS 24 1.3.3 YEARS CONSIDERED 25 1.3.4 CURRENCY CONSIDERED 25 1.4 STAKEHOLDERS 26 1.5 SUMMARY OF CHANGES 26 2 EXECUTIVE SUMMARY 27 2.1 KEY INSIGHTS AND MARKET HIGHLIGHTS 27 2.2 KEY MARKET PARTICIPANTS: SHARE INSIGHTS AND START DEVELOPMENTS 29 2.3 DISRUPTIVE TRENDS SHAPING MARKET 30 2.4 HIGH-GROWTH SEGMENTS & EMERGING FRONTIERS 31 2.5 SNAPSHOT: GLOBAL MARKET SIZE, GROWTH RATE, AND FORECAST 32 3 PREMIUM INSIGHTS 33 3.1 PHOTOTHERAPY EQUIPMENTS MARKET OVERVIEW 33 3.2 ASIA PACIFIC: PHOTOTHERAPY EQUIPMENT MARKET, BY END USER 34 3.3 PHOTOTHERAPY EQUIPMENT MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 35 3.4 PHOTOTHERAPY EQUIPMENT MARKET: REGIONAL MIX 35 3.5 PHOTOTHERAPY EQUIPMENT MARKET: DEVELOPED COUNTRIES VS. EMERGING ECONOMIES 36 4 MARKET OVERVIEW 37 4.1 INTRODUCTION 37 4.2 MARKET DYNAMICS 37 4.2.1 DRIVERS 38 4.2.1.1 Rising incidence of neonatal jaundice 38 4.2.1.2 Growing number of preterm and low-weight births 38 4.2.1.3 Rising prevalence of skin diseases 39 4.2.1.4 Launch of technologically advanced phototherapy equipment 40 4.2.1.5 Rising adoption of LED-based phototherapy equipment 40 4.2.2 RESTRAINTS 41 4.2.2.1 High use of alternative modes of treatment 41 4.2.2.2 Stringent regulatory policies for new device approval 42 4.2.3 OPPORTUNITIES 42 4.2.3.1 Development of low-cost phototherapy equipment 42 4.2.3.2 Rising adoption of home phototherapy for treating skin diseases 43 4.2.4 CHALLENGES 44 4.2.4.1 Rising trend of purchasing refurbished equipment in emerging markets 44 4.2.4.2 Limited adoption of phototherapy equipment in developing nations 44 4.3 UNMET NEEDS AND WHITE SPACES 45 4.3.1 UNMET NEEDS IN PHOTOTHERAPY EQUIPMENT MARKET 45 4.3.2 WHITE SPACE OPPORTUNITIES 45 4.4 INTERCONNECTED MARKETS AND CROSS-SECTOR OPPORTUNITIES 46 4.4.1 INTERCONNECTED MARKETS 46 4.4.2 CROSS-SECTOR OPPORTUNITIES 46 4.5 STRATEGIC MOVES BY TIER-1/2/3 PLAYERS 47 5 INDUSTRY TRENDS 48 5.1 PORTER’S FIVE FORCES ANALYSIS 48 5.1.1 THREAT OF NEW ENTRANTS 49 5.1.2 THREAT OF SUBSTITUTES 49 5.1.3 BARGAINING POWER OF BUYERS 50 5.1.4 BARGAINING POWER OF SUPPLIERS 50 5.1.5 INTENSITY OF COMPETITIVE RIVALRY 50 5.2 MACROECONOMIC OUTLOOK 50 5.2.1 INTRODUCTION 50 5.2.2 GDP TRENDS AND FORECAST 51 5.2.3 TRENDS IN GLOBAL NEONATAL & DERMATOLOGY CARE INDUSTRY 53 5.3 SUPPLY CHAIN ANALYSIS 53 5.4 VALUE CHAIN ANALYSIS 55 5.5 ECOSYSTEM ANALYSIS 56 5.6 PRICING ANALYSIS 57 5.6.1 AVERAGE SELLING PRICE TREND, BY KEY PLAYER (2025) 57 5.6.2 AVERAGE SELLING PRICE TREND, BY REGION (2024–2026) 58 5.7 TRADE ANALYSIS 59 5.7.1 IMPORT SCENARIO (HS CODE 9018090) 59 5.7.2 EXPORT SCENARIO (HS CODE 9018090) 60 5.8 KEY CONFERENCES AND EVENTS, 2026–2027 60 5.9 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 61 5.10 INVESTMENT & FUNDING SCENARIO 62 5.11 CASE STUDY ANALYSIS 63 5.11.1 CASE STUDY 1: SMART NICU UPGRADE AT BOSTON CHILDREN’S HOSPITAL 63 5.11.2 CASE STUDY 2: AFFORDABLE PHOTOTHERAPY EXPANSION IN RURAL INDIA 63 5.11.3 CASE STUDY 3: PREDICTIVE NEONATAL MONITORING AT MOUNT SINAI HOSPITAL, CANADA 63 5.12 IMPACT OF US TARIFFS—PHOTOTHERAPY EQUIPMENT MARKET 63 5.12.1 INTRODUCTION 63 5.12.2 KEY TARIFF RATES 64 5.12.3 PRICE IMPACT ANALYSIS 65 5.12.4 IMPACT ON COUNTRIES/REGIONS 65 5.12.4.1 North America 65 5.12.4.2 Europe 66 5.12.4.3 Asia Pacific 66 5.12.5 END-USE INDUSTRY IMPACT 66 6 TECHNOLOGICAL ADVANCEMENTS, AI-DRIVEN IMPACT, PATENTS, INNOVATIONS, AND FUTURE APPLICATIONS 67 6.1 KEY EMERGING TECHNOLOGIES 67 6.1.1 ADVANCED LED PHOTOTHERAPY SYSTEMS 67 6.1.2 FIBER-OPTIC & WEARABLE PHOTOTHERAPY TECHNOLOGIES 67 6.2 COMPLEMENTARY TECHNOLOGIES 67 6.2.1 BIOSENSOR & CHEMICAL SENSOR TECHNOLOGIES 68 6.2.2 POINT-OF-CARE & HOME CARE TREATMENT PLATFORMS 68 6.3 TECHNOLOGY/PRODUCT ROADMAP 68 6.3.1 SHORT-TERM (2025–2027) | FOUNDATION & EARLY COMMERCIALIZATION 68 6.3.2 MID-TERM (2027–2030) | EXPANSION & STANDARDIZATION 69 6.3.3 LONG-TERM (2030–2035+) | MASS COMMERCIALIZATION & DISRUPTION 69 6.4 PATENT ANALYSIS 70 6.4.1 INSIGHTS: JURISDICTION AND TOP APPLICANT ANALYSIS 71 6.5 FUTURE APPLICATIONS 72 6.5.1 AI-ENABLED SMART PHOTOTHERAPY & CONNECTED CARE SYSTEMS 72 6.5.2 NON-INVASIVE MEDICAL BREATH DIAGNOSTICS 73 6.5.3 NEXT-GENERATION LED & PRECISION PHOTOTHERAPY TECHNOLOGIES 73 6.6 IMPACT OF AI/GEN AI ON PHOTOTHERAPY EQUIPMENT MARKET 73 6.6.1 TOP USE CASES AND MARKET POTENTIAL 74 6.6.2 BEST PRACTICES FOLLOWED BY MANUFACTURERS/OEMS IN PHOTOTHERAPY EQUIPMENT MARKET 74 6.6.3 CASE STUDIES OF AI IMPLEMENTATION IN PHOTOTHERAPY EQUIPMENT 75 6.6.4 INTERCONNECTED ADJACENT ECOSYSTEMS AND IMPACT ON MARKET PLAYERS 76 6.6.5 CLIENTS’ READINESS TO ADOPT GENERATIVE AI IN PHOTOTHERAPY EQUIPMENT MARKET 77 7 CUSTOMER LANDSCAPE & BUYER BEHAVIOR 78 7.1 DECISION-MAKING PROCESS 78 7.2 KEY STAKEHOLDERS INVOLVED IN BUYING PROCESS AND THEIR EVALUATION CRITERIA 78 7.2.1 KEY STAKEHOLDERS IN BUYING PROCESS 78 7.2.2 KEY BUYING CRITERIA 79 7.3 ADOPTION BARRIERS & INTERNAL CHALLENGES 80 7.4 UNMET NEEDS OF VARIOUS END-USE INDUSTRIES 81 7.5 MARKET PROFITABILITY 81 7.5.1 REVENUE POTENTIAL 82 7.5.2 COST DYNAMICS 82 7.5.3 MARGIN OPPORTUNITIES IN KEY APPLICATIONS 82 8 REGULATORY LANDSCAPE 83 8.1 REGIONAL REGULATIONS AND COMPLIANCE 83 8.1.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 83 8.1.2 INDUSTRY STANDARDS 85 9 PHOTOTHERAPY EQUIPMENT MARKET, BY PRODUCT 86 9.1 INTRODUCTION 87 9.2 CONVENTIONAL PHOTOTHERAPY 87 9.2.1 AFFORDABILITY AND ACCESSIBILITY DRIVING CONTINUED USE OF CONVENTIONAL PHOTOTHERAPY EQUIPMENT 87 9.3 FIBER-OPTIC PHOTOTHERAPY 89 9.3.1 PARENT-FRIENDLY DESIGN AND HOME-BASED CARE DEMAND ACCELERATE GROWTH IN FIBER-OPTIC PHOTOTHERAPY 89 10 PHOTOTHERAPY EQUIPMENT MARKET, BY APPLICATION 92 10.1 INTRODUCTION 93 10.2 NEONATAL JAUNDICE 93 10.2.1 INCREASING NUMBER OF PRETERM AND LOW-WEIGHT BIRTHS TO DRIVE MARKET GROWTH 93 10.3 SKIN DISEASES 94 10.3.1 PSORIASIS 96 10.3.1.1 Rising demand for non-invasive therapies and technological advancements to drive market 96 10.3.2 VITILIGO 97 10.3.2.1 High effectiveness in managing vitiligo drives market growth 97 10.3.3 ECZEMA 99 10.3.3.1 Growing burden of pediatric eczema to support demand for phototherapy 99 11 PHOTOTHERAPY EQUIPMENT MARKET, BY END USER 101 11.1 INTRODUCTION 102 11.2 HOSPITALS 102 11.2.1 RISING PATIENT ADMISSIONS AND ADVANCED TREATMENT INFRASTRUCTURE SUPPORT DOMINANCE OF HOSPITALS 102 11.3 HOME CARE SETTINGS 103 11.3.1 INCREASING ADOPTION OF PORTABLE AND HOME-USE DEVICES TO DRIVE MARKET GROWTH 103 12 PHOTOTHERAPY EQUIPMENT MARKET, BY REGION 105 12.1 INTRODUCTION 106 12.2 NORTH AMERICA 107 12.2.1 US 109 12.2.1.1 Government initiatives and technological advancements supporting market growth 109 12.2.2 CANADA 111 12.2.2.1 Expansion of neonatal care services and home-based phototherapy adoption driving market growth 111 12.3 EUROPE 113 12.3.1 GERMANY 115 12.3.1.1 Advanced healthcare infrastructure and innovation leadership driving market growth 115 12.3.2 UK 117 12.3.2.1 NHS modernization and increasing dermatology treatment demand supporting market growth 117 12.3.3 FRANCE 119 12.3.3.1 Public healthcare investments and rising neonatal care demand driving market growth 119 12.3.4 ITALY 121 12.3.4.1 Healthcare modernization and rising awareness of skin disease treatments supporting market growth 121 12.3.5 SPAIN 123 12.3.5.1 Rising neonatal healthcare investments and dermatology treatment adoption are driving growth 123 12.3.6 REST OF EUROPE 125 12.4 ASIA PACIFIC 127 12.4.1 CHINA 130 12.4.1.1 Healthcare expansion and domestic medical device manufacturing driving market growth 130 12.4.2 JAPAN 131 12.4.2.1 Aging population and advanced healthcare technologies supporting market growth 131 12.4.3 INDIA 133 12.4.3.1 Rising neonatal healthcare demand and government healthcare initiatives driving market growth 133 12.4.4 AUSTRALIA 135 12.4.4.1 Expansion of neonatal healthcare programs and dermatology services supporting market growth 135 12.4.5 SOUTH KOREA 137 12.4.5.1 Technological innovation and expanding dermatology care driving market growth 137 12.4.6 REST OF ASIA PACIFIC 139 12.5 LATIN AMERICA 141 12.5.1 BRAZIL 143 12.5.1.1 Expanding neonatal healthcare services and growing dermatology market supporting growth 143 12.5.2 MEXICO 145 12.5.2.1 Healthcare modernization and increasing neonatal care awareness driving market growth 145 12.5.3 REST OF LATIN AMERICA 147 12.6 MIDDLE EAST & AFRICA 149 12.7 GCC COUNTRIES 150 13 COMPETITIVE LANDSCAPE 153 13.1 OVERVIEW 153 13.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 153 13.3 REVENUE ANALYSIS 155 13.4 MARKET SHARE ANALYSIS 156 13.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2025 157 13.5.1 STARS 157 13.5.2 EMERGING LEADERS 157 13.5.3 PERVASIVE PLAYERS 158 13.5.4 PARTICIPANTS 158 13.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2025 159 13.5.5.1 Company footprint 159 13.5.5.2 Region footprint 160 13.5.5.3 Product footprint 160 13.5.5.4 Application footprint 161 13.5.5.5 End-user footprint 161 13.6 COMPETITIVE EVALUATION MATRIX: STARTUPS/SMES, 2025 162 13.6.1 PROGRESSIVE COMPANIES 162 13.6.2 RESPONSIVE COMPANIES 162 13.6.3 DYNAMIC COMPANIES 162 13.6.4 STARTING BLOCKS 162 13.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2025 164 13.6.5.1 Detailed list of key startups/SMEs 164 13.6.5.2 Competitive benchmarking of startups/SMEs 165 13.7 COMPANY VALUATION AND FINANCIAL METRICS 166 13.7.1 FINANCIAL METRICS 166 13.7.2 COMPANY VALUATION 166 13.8 BRAND COMPARISON 167 13.9 COMPETITIVE SCENARIO 168 13.9.1 PRODUCT LAUNCHES & APPROVALS 168 13.9.2 DEALS 169 14 COMPANY PROFILES 171 14.1 KEY PLAYERS 171 14.1.1 GE HEALTHCARE 171 14.1.1.1 Business overview 171 14.1.1.2 Products offered 172 14.1.1.3 MnM view 173 14.1.1.3.1 Right to win 173 14.1.1.3.2 Strategic choices 173 14.1.1.3.3 Weaknesses and competitive threats 173 14.1.2 DRÄGERWERK AG & CO. KGAA 174 14.1.2.1 Business overview 174 14.1.2.2 Products offered 175 14.1.2.3 Recent developments 176 14.1.2.3.1 Product launches 176 14.1.2.4 MnM view 176 14.1.2.4.1 Right to win 176 14.1.2.4.2 Strategic choices 176 14.1.2.4.3 Weaknesses and competitive threats 176 14.1.3 NATUS SENSORY 177 14.1.3.1 Business overview 177 14.1.3.2 Products offered 177 14.1.3.3 Recent developments 178 14.1.3.3.1 Deals 178 14.1.3.4 MnM view 179 14.1.3.4.1 Key strengths/Right to win 179 14.1.3.4.2 Strategic choices made 179 14.1.3.4.3 Weaknesses and competitive threats 179 14.1.4 PHOTHERA 180 14.1.4.1 Business overview 180 14.1.4.2 Products offered 180 14.1.4.3 Recent developments 182 14.1.4.3.1 Product launches 182 14.1.4.4 MnM view 182 14.1.4.4.1 Key strengths/Right to win 182 14.1.4.4.2 Strategic choices made 182 14.1.4.4.3 Weaknesses and competitive threats 183 14.1.5 SHANGHAI SIGMA HIGH-TECH CO., LTD. 184 14.1.5.1 Business overview 184 14.1.5.2 Products offered 184 14.1.5.3 Recent developments 185 14.1.5.3.1 Product launches 185 14.1.5.4 MnM view 186 14.1.5.4.1 Right to win 186 14.1.5.4.2 Strategic choices 186 14.1.5.4.3 Weaknesses and competitive threats 187 14.1.6 ATOM MEDICAL CORP 188 14.1.6.1 Business overview 188 14.1.6.2 Products offered 188 14.1.7 PHOENIX MEDICAL SYSTEMS 189 14.1.7.1 Business overview 189 14.1.7.2 Products offered 189 14.1.8 NEOLIGHT LLC 190 14.1.8.1 Business overview 190 14.1.8.2 Products offered 190 14.1.8.3 Recent developments 191 14.1.8.3.1 Deals 191 14.1.9 FANEM 192 14.1.9.1 Business overview 192 14.1.9.2 Products offered 193 14.1.10 BISTOS CO., LTD. 194 14.1.10.1 Business overview 194 14.1.10.2 Products offered 194 14.2 OTHER PLAYERS 195 14.2.1 NINGBO DAVID MEDICAL DEVICE CO., LTD. 195 14.2.2 STRATA SKIN SCIENCES 196 14.2.3 XUZHOU KERNEL MEDICAL EQUIPMENT CO., LTD. 197 14.2.4 ULTRALITE ENTERPRISES, INC. 198 14.2.5 HOENLE MEDICAL GMBH 199 14.2.6 WEYER GMBH 199 14.2.7 SHENZHEN COMEN MEDICAL INSTRUMENTS CO., LTD. 200 14.2.8 THERALIGHT, LLC 201 14.2.9 ATHRODAX LTD 202 14.2.10 CURELIGHT 203 14.2.11 PHOTO THERAPEUTICS LTD 204 14.2.12 TINY HEARTS TECHNOLOGY 205 14.2.13 LIFETRONS INNO EQUIPMENTS PVT LTD 205 14.2.14 IBIS MEDICAL EQUIPMENT AND SYSTEMS PVT LTD 206 14.2.15 SCI HEALTH 207 15 RESEARCH METHODOLOGY 208 15.1 RESEARCH DATA 208 15.1.1 SECONDARY DATA 209 15.1.1.1 Key data from secondary sources 210 15.1.2 PRIMARY DATA 210 15.1.2.1 Key data from primary sources 211 15.1.2.2 Key industry insights 212 15.2 MARKET SIZE ESTIMATION 214 15.3 MARKET BREAKDOWN AND DATA TRIANGULATION 219 15.4 MARKET SHARE ESTIMATION 220 15.5 STUDY ASSUMPTIONS 220 15.6 METHODOLOGY-RELATED LIMITATIONS 220 15.7 RISK ASSESSMENT 221 15.8 RESEARCH LIMITATIONS 221 16 APPENDIX 222 16.1 DISCUSSION GUIDE 222 16.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 225 16.3 CUSTOMIZATION OPTIONS 227 16.4 RELATED REPORTS 227 16.5 AUTHOR DETAILS 228

圖表清單 List of Tables & Figures

TABLE 1 STANDARD CURRENCY CONVERSION RATES TO USD 25 TABLE 2 PHOTOTHERAPY EQUIPMENT MARKET: PORTER’S FIVE FORCES ANALYSIS 48 TABLE 3 GDP PERCENTAGE CHANGE, BY KEY COUNTRY, 2021–2030 51 TABLE 4 AVERAGE SELLING PRICE TREND OF PHOTOTHERAPY PRODUCTS, BY KEY PLAYER 2025 (USD) 58 TABLE 5 AVERAGE PRICING TREND OF PHOTOTHERAPY PRODUCTS, BY REGION, 2024–2026 (USD) 58 TABLE 6 IMPORT DATA FOR PHOTOTHERAPY EQUIPMENT PRODUCTS UNDER HS CODE 9018090, BY COUNTRY, 2021–2025 (USD THOUSAND) 59 TABLE 7 EXPORT DATA FOR PHOTOTHERAPY EQUIPMENT UNDER HS CODE 903180, BY COUNTRY, 2020–2024 (USD THOUSAND) 60 TABLE 8 PHOTOTHERAPY EQUIPMENT MARKET: DETAILED LIST OF KEY CONFERENCES AND EVENTS (2026-2027) 60 TABLE 9 US-ADJUSTED RECIPROCAL TARIFF RATES 64 TABLE 10 KEY PRODUCT-RELATED TARIFF EFFECTIVE FOR PHOTOTHERAPY EQUIPMENT 65 TABLE 11 TOP USE CASES AND MARKET POTENTIAL 74 TABLE 12 PHOTOTHERAPY EQUIPMENT MARKET: CASE STUDIES RELATED TO AI IMPLEMENTATION 75 TABLE 13 INTERCONNECTED ADJACENT ECOSYSTEMS AND IMPACT ON MARKET PLAYERS 76 TABLE 14 INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS OF PHOTOTHERAPY EQUIPMENT 79 TABLE 15 KEY BUYING CRITERIA FOR PHOTOTHERAPY EQUIPMENT 80 TABLE 16 PHOTOTHERAPY EQUIPMENT MARKET: UNMET NEEDS/END-USER EXPECTATIONS 81 TABLE 17 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 83 TABLE 18 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 83 TABLE 19 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 84 TABLE 20 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 84 TABLE 21 MIDDLE EAST & AFRICA AND GCC COUNTRIES: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 84 TABLE 22 GLOBAL STANDARDS IN PHOTOTHERAPY EQUIPMENT MARKET 85 TABLE 23 PHOTOTHERAPY EQUIPMENT MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 87 TABLE 24 CONVENTIONAL PHOTOTHERAPY EQUIPMENT MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 88 TABLE 25 CONVENTIONAL PHOTOTHERAPY EQUIPMENT MARKET VOLUME, BY REGION, 2024–2031 (UNITS) 88 TABLE 26 FIBER-OPTIC PHOTOTHERAPY EQUIPMENT MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 90 TABLE 27 FIBER-OPTIC PHOTOTHERAPY EQUIPMENT MARKET VOLUME, BY REGION, 2024–2031 (UNITS) 91 TABLE 28 PHOTOTHERAPY EQUIPMENT MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 93 TABLE 29 PHOTOTHERAPY EQUIPMENT MARKET FOR NEONATAL JAUNDICE, BY COUNTRY, 2024–2031 (USD MILLION) 94 TABLE 30 PHOTOTHERAPY EQUIPMENT MARKET FOR SKIN DISEASES, BY TYPE, 2024–2031 (USD MILLION) 95 TABLE 31 PHOTOTHERAPY EQUIPMENT MARKET FOR SKIN DISEASES, BY COUNTRY, 2024–2031 (USD MILLION) 95 TABLE 32 PHOTOTHERAPY EQUIPMENT MARKET FOR PSORIASIS, BY COUNTRY, 2024–2031 (USD MILLION) 97 TABLE 33 PHOTOTHERAPY EQUIPMENT MARKET FOR VITILIGO, BY COUNTRY, 2024–2031 (USD MILLION) 99 TABLE 34 PHOTOTHERAPY EQUIPMENT MARKET FOR ECZEMA, BY COUNTRY, 2024–2031 (USD MILLION) 100 TABLE 35 PHOTOTHERAPY EQUIPMENT MARKET BY END USER, 2024–2031 (USD MILLION) 102 TABLE 36 PHOTOTHERAPY EQUIPMENT MARKET FOR HOSPITALS, BY COUNTRY, 2024–2031 (USD MILLION) 103 TABLE 37 PHOTOTHERAPY EQUIPMENT MARKET FOR HOME CARE SETTINGS, BY COUNTRY, 2024–2031 (USD MILLION) 104 TABLE 38 PHOTOTHERAPY EQUIPMENT MARKET, BY REGION, 2024–2031 (USD MILLION) 106 TABLE 39 NORTH AMERICA: PHOTOTHERAPY EQUIPMENT MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 107 TABLE 40 NORTH AMERICA: PHOTOTHERAPY EQUIPMENT MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 108 TABLE 41 NORTH AMERICA: PHOTOTHERAPY EQUIPMENT MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 108 TABLE 42 NORTH AMERICA: PHOTOTHERAPY EQUIPMENT MARKET FOR SKIN DISEASES, BY TYPE, 2024–2031 (USD MILLION) 108 TABLE 43 NORTH AMERICA: PHOTOTHERAPY EQUIPMENT MARKET, BY END USER, 2024–2031 (USD MILLION) 109 TABLE 44 US: PHOTOTHERAPY EQUIPMENT MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 110 TABLE 45 US: PHOTOTHERAPY EQUIPMENT MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 110 TABLE 46 US: PHOTOTHERAPY EQUIPMENT MARKET FOR SKIN DISEASES, BY TYPE, 2024–2031 (USD MILLION) 110 TABLE 47 US: PHOTOTHERAPY EQUIPMENT MARKET, BY END USER, 2024–2031 (USD MILLION) 111 TABLE 48 CANADA: PHOTOTHERAPY EQUIPMENT MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 112 TABLE 49 CANADA: PHOTOTHERAPY EQUIPMENT MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 112 TABLE 50 CANADA: PHOTOTHERAPY EQUIPMENT MARKET FOR SKIN DISEASES, BY TYPE, 2024–2031 (USD MILLION) 112 TABLE 51 CANADA: PHOTOTHERAPY EQUIPMENT MARKET, BY END USER, 2024–2031 (USD MILLION) 113 TABLE 52 EUROPE: PHOTOTHERAPY EQUIPMENT MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 113 TABLE 53 EUROPE: PHOTOTHERAPY EQUIPMENT MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 114 TABLE 54 EUROPE: PHOTOTHERAPY EQUIPMENT MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 114 TABLE 55 EUROPE: PHOTOTHERAPY EQUIPMENT MARKET FOR SKIN DISEASES, BY TYPE, 2024–2031 (USD MILLION) 114 TABLE 56 EUROPE: PHOTOTHERAPY EQUIPMENT MARKET, BY END USER, 2024–2031 (USD MILLION) 115 TABLE 57 GERMANY: PHOTOTHERAPY EQUIPMENT MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 116 TABLE 58 GERMANY: PHOTOTHERAPY EQUIPMENT MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 116 TABLE 59 GERMANY: PHOTOTHERAPY EQUIPMENT MARKET FOR SKIN DISEASES, BY TYPE, 2024–2031 (USD MILLION) 116 TABLE 60 GERMANY: PHOTOTHERAPY EQUIPMENT MARKET, BY END USER, 2024–2031 (USD MILLION) 117 TABLE 61 UK: PHOTOTHERAPY EQUIPMENT MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 118 TABLE 62 UK: PHOTOTHERAPY EQUIPMENT MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 118 TABLE 63 UK: PHOTOTHERAPY EQUIPMENT MARKET FOR SKIN DISEASES, BY TYPE, 2024–2031 (USD MILLION) 118 TABLE 64 UK: PHOTOTHERAPY EQUIPMENT MARKET, BY END USER, 2024–2031 (USD MILLION) 119 TABLE 65 FRANCE: PHOTOTHERAPY EQUIPMENT MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 120 TABLE 66 FRANCE: PHOTOTHERAPY EQUIPMENT MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 120 TABLE 67 FRANCE: PHOTOTHERAPY EQUIPMENT MARKET FOR SKIN DISEASES, BY TYPE, 2024–2031 (USD MILLION) 120 TABLE 68 FRANCE: PHOTOTHERAPY EQUIPMENT MARKET, BY END USER, 2024–2031 (USD MILLION) 121 TABLE 69 ITALY: PHOTOTHERAPY EQUIPMENT MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 122 TABLE 70 ITALY: PHOTOTHERAPY EQUIPMENT MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 122 TABLE 71 ITALY: PHOTOTHERAPY EQUIPMENT MARKET FOR SKIN DISEASES, BY TYPE, 2024–2031 (USD MILLION) 122 TABLE 72 ITALY: PHOTOTHERAPY EQUIPMENT MARKET, BY END USER, 2024–2031 (USD MILLION) 123 TABLE 73 SPAIN: PHOTOTHERAPY EQUIPMENT MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 124 TABLE 74 SPAIN: PHOTOTHERAPY EQUIPMENT MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 124 TABLE 75 SPAIN: PHOTOTHERAPY EQUIPMENT MARKET FOR SKIN DISEASES, BY TYPE, 2024–2031 (USD MILLION) 124 TABLE 76 SPAIN: PHOTOTHERAPY EQUIPMENT MARKET, BY END USER, 2024–2031 (USD MILLION) 125 TABLE 77 REST OF EUROPE: PHOTOTHERAPY EQUIPMENT MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 126 TABLE 78 REST OF EUROPE: PHOTOTHERAPY EQUIPMENT MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 126 TABLE 79 REST OF EUROPE: PHOTOTHERAPY EQUIPMENT MARKET FOR SKIN DISEASES, BY TYPE, 2024–2031 (USD MILLION) 126 TABLE 80 REST OF EUROPE: PHOTOTHERAPY EQUIPMENT MARKET, BY END USER, 2024–2031 (USD MILLION) 127 TABLE 81 ASIA PACIFIC: PHOTOTHERAPY EQUIPMENT MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 128 TABLE 82 ASIA PACIFIC: PHOTOTHERAPY EQUIPMENT MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 128 TABLE 83 ASIA PACIFIC: PHOTOTHERAPY EQUIPMENT MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 129 TABLE 84 ASIA PACIFIC: PHOTOTHERAPY EQUIPMENT MARKET FOR SKIN DISEASES, BY TYPE, 2024–2031 (USD MILLION) 129 TABLE 85 ASIA PACIFIC: PHOTOTHERAPY EQUIPMENT MARKET, BY END USER, 2024–2031 (USD MILLION) 129 TABLE 86 CHINA: PHOTOTHERAPY EQUIPMENT MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 130 TABLE 87 CHINA: PHOTOTHERAPY EQUIPMENT MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 130 TABLE 88 CHINA: PHOTOTHERAPY EQUIPMENT MARKET FOR SKIN DISEASES, BY TYPE, 2024–2031 (USD MILLION) 131 TABLE 89 CHINA: PHOTOTHERAPY EQUIPMENT MARKET, BY END USER, 2024–2031 (USD MILLION) 131 TABLE 90 JAPAN: PHOTOTHERAPY EQUIPMENT MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 132 TABLE 91 JAPAN: PHOTOTHERAPY EQUIPMENT MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 132 TABLE 92 JAPAN: PHOTOTHERAPY EQUIPMENT MARKET FOR SKIN DISEASES, BY TYPE, 2024–2031 (USD MILLION) 132 TABLE 93 JAPAN: PHOTOTHERAPY EQUIPMENT MARKET, BY END USER, 2024–2031 (USD MILLION) 133 TABLE 94 INDIA: PHOTOTHERAPY EQUIPMENT MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 134 TABLE 95 INDIA: PHOTOTHERAPY EQUIPMENT MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 134 TABLE 96 INDIA: PHOTOTHERAPY EQUIPMENT MARKET FOR SKIN DISEASES, BY TYPE, 2024–2031 (USD MILLION) 134 TABLE 97 INDIA: PHOTOTHERAPY EQUIPMENT MARKET, BY END USER, 2024–2031 (USD MILLION) 135 TABLE 98 AUSTRALIA: PHOTOTHERAPY EQUIPMENT MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 136 TABLE 99 AUSTRALIA: PHOTOTHERAPY EQUIPMENT MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 136 TABLE 100 AUSTRALIA: PHOTOTHERAPY EQUIPMENT MARKET FOR SKIN DISEASES, BY TYPE, 2024–2031 (USD MILLION) 136 TABLE 101 AUSTRALIA: PHOTOTHERAPY EQUIPMENT MARKET, BY END USER, 2024–2031 (USD MILLION) 137 TABLE 102 SOUTH KOREA: PHOTOTHERAPY EQUIPMENT MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 138 TABLE 103 SOUTH KOREA: PHOTOTHERAPY EQUIPMENT MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 138 TABLE 104 SOUTH KOREA: PHOTOTHERAPY EQUIPMENT MARKET FOR SKIN DISEASES, BY TYPE, 2024–2031 (USD MILLION) 138 TABLE 105 SOUTH KOREA: PHOTOTHERAPY EQUIPMENT MARKET, BY END USER, 2024–2031 (USD MILLION) 139 TABLE 106 REST OF ASIA PACIFIC: PHOTOTHERAPY EQUIPMENT MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 140 TABLE 107 REST OF ASIA PACIFIC: PHOTOTHERAPY EQUIPMENT MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 140 TABLE 108 REST OF ASIA PACIFIC: PHOTOTHERAPY EQUIPMENT MARKET FOR SKIN DISEASES, BY TYPE, 2024–2031 (USD MILLION) 140 TABLE 109 REST OF ASIA PACIFIC: PHOTOTHERAPY EQUIPMENT MARKET, BY END USER, 2024–2031 (USD MILLION) 141 TABLE 110 LATIN AMERICA: PHOTOTHERAPY EQUIPMENT MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 142 TABLE 111 LATIN AMERICA: PHOTOTHERAPY EQUIPMENT MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 142 TABLE 112 LATIN AMERICA: PHOTOTHERAPY EQUIPMENT MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 142 TABLE 113 LATIN AMERICA: PHOTOTHERAPY EQUIPMENT MARKET FOR SKIN DISEASES, BY TYPE, 2024–2031 (USD MILLION) 143 TABLE 114 LATIN AMERICA: PHOTOTHERAPY EQUIPMENT MARKET, BY END USER, 2024–2031 (USD MILLION) 143 TABLE 115 BRAZIL: PHOTOTHERAPY EQUIPMENT MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 144 TABLE 116 BRAZIL: PHOTOTHERAPY EQUIPMENT MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 144 TABLE 117 BRAZIL: PHOTOTHERAPY EQUIPMENT MARKET FOR SKIN DISEASES, BY TYPE, 2024–2031 (USD MILLION) 144 TABLE 118 BRAZIL: PHOTOTHERAPY EQUIPMENT MARKET, BY END USER, 2024–2031 (USD MILLION) 145 TABLE 119 MEXICO: PHOTOTHERAPY EQUIPMENT MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 146 TABLE 120 MEXICO: PHOTOTHERAPY EQUIPMENT MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 146 TABLE 121 MEXICO: PHOTOTHERAPY EQUIPMENT MARKET FOR SKIN DISEASES, BY TYPE, 2024–2031 (USD MILLION) 146 TABLE 122 MEXICO: PHOTOTHERAPY EQUIPMENT MARKET, BY END USER, 2024–2031 (USD MILLION) 147 TABLE 123 REST OF LATIN AMERICA: PHOTOTHERAPY EQUIPMENT MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 147 TABLE 124 REST OF LATIN AMERICA: PHOTOTHERAPY EQUIPMENT MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 148 TABLE 125 REST OF LATIN AMERICA: PHOTOTHERAPY EQUIPMENT MARKET FOR SKIN DISEASES, BY TYPE, 2024–2031 (USD MILLION) 148 TABLE 126 REST OF LATIN AMERICA: PHOTOTHERAPY EQUIPMENT MARKET, BY END USER, 2024–2031 (USD MILLION) 148 TABLE 127 MIDDLE EAST & AFRICA: PHOTOTHERAPY EQUIPMENT MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 149 TABLE 128 MIDDLE EAST & AFRICA: PHOTOTHERAPY EQUIPMENT MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 149 TABLE 129 MIDDLE EAST & AFRICA: PHOTOTHERAPY EQUIPMENT MARKET FOR SKIN DISEASES, BY TYPE, 2024–2031 (USD MILLION) 150 TABLE 130 MIDDLE EAST & AFRICA: PHOTOTHERAPY EQUIPMENT MARKET, BY END USER, 2024–2031 (USD MILLION) 150 TABLE 131 GCC COUNTRIES: PHOTOTHERAPY EQUIPMENT MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 151 TABLE 132 GCC COUNTRIES: PHOTOTHERAPY EQUIPMENT MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 151 TABLE 133 GCC COUNTRIES: PHOTOTHERAPY EQUIPMENT MARKET FOR SKIN DISEASES, BY TYPE, 2024–2031 (USD MILLION) 151 TABLE 134 GCC COUNTRIES: PHOTOTHERAPY EQUIPMENT MARKET, BY END USER, 2024–2031 (USD MILLION) 152 TABLE 135 KEY DEVELOPMENTS IN PHOTOTHERAPY EQUIPMENT MARKET, JANUARY 2021–MAY 2026 153 TABLE 136 PHOTOTHERAPY EQUIPMENT MARKET: DEGREE OF COMPETITION 156 TABLE 137 PHOTOTHERAPY EQUIPMENT MARKET: REGION FOOTPRINT 160 TABLE 138 PHOTOTHERAPY EQUIPMENT MARKET: PRODUCT FOOTPRINT 160 TABLE 139 PHOTOTHERAPY EQUIPMENT MARKET: APPLICATION FOOTPRINT 161 TABLE 140 PHOTOTHERAPY EQUIPMENT MARKET: END-USER FOOTPRINT 161 TABLE 141 PHOTOTHERAPY EQUIPMENT MARKET: DETAILED LIST OF KEY STARTUPS/SMES 164 TABLE 142 PHOTOTHERAPY EQUIPMENT MARKET: COMPETITIVE BENCHMARKING OF STARTUPS/SMES 165 TABLE 143 PHOTOTHERAPY EQUIPMENT MARKET: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021–JANUARY 2026 168 TABLE 144 PHOTOTHERAPY EQUIPMENT MARKET: DEALS, JANUARY 2021–JANUARY 2026 169 TABLE 145 GE HEALTHCARE: COMPANY OVERVIEW 171 TABLE 146 GE HEALTHCARE: PRODUCTS OFFERED 172 TABLE 147 DRÄGERWERK AG & CO. KGAA: COMPANY OVERVIEW 174 TABLE 148 DRÄGERWERK AG & CO. KGAA: PRODUCTS OFFERED 175 TABLE 149 DRÄGERWERK AG & CO. KGAA: PRODUCT LAUNCHES, JANUARY 2021–MAY 2026 176 TABLE 150 NATUS SENSORY: COMPANY OVERVIEW 177 TABLE 151 NATUS SENSORY: PRODUCTS OFFERED 177 TABLE 152 NATUS SENSORY: DEALS, JANUARY 2021–MAY 2026 178 TABLE 153 PHOTHERA: COMPANY OVERVIEW 180 TABLE 154 PHOTHERA: PRODUCTS OFFERED 180 TABLE 155 PHOTHERA: PRODUCT LAUNCHES, JANUARY 2021–MAY 2026 182 TABLE 156 SHANGHAI SIGMA HIGH-TECH CO., LTD.: COMPANY OVERVIEW 184 TABLE 157 SHANGHAI SIGMA HIGH-TECH CO., LTD.: PRODUCTS OFFERED 184 TABLE 158 SHANGHAI SIGMA HIGH-TECH CO., LTD.: PRODUCT LAUNCHES, JANUARY 2021–MAY 2026 185 TABLE 159 ATOM MEDICAL CORP: COMPANY OVERVIEW 188 TABLE 160 ATOM MEDICAL CORP: PRODUCTS OFFERED 188 TABLE 161 PHOENIX MEDICAL SYSTEMS: COMPANY OVERVIEW 189 TABLE 162 PHOENIX MEDICAL SYSTEMS: PRODUCTS OFFERED 189 TABLE 163 NEOLIGHT LLC: COMPANY OVERVIEW 190 TABLE 164 NEOLIGHT LLC: PRODUCTS OFFERED 190 TABLE 165 NEOLIGHT LLC: DEALS, JANUARY 2021–MAY 2026 191 TABLE 166 FANEM: COMPANY OVERVIEW 192 TABLE 167 FANEM: PRODUCTS OFFERED 193 TABLE 168 BISTOS CO., LTD.: COMPANY OVERVIEW 194 TABLE 169 BISTOS CO., LTD.: PRODUCTS OFFERED 194 TABLE 170 NINGBO DAVID MEDICAL DEVICE CO., LTD.: COMPANY OVERVIEW 195 TABLE 171 STRATA SKIN SCIENCES: COMPANY OVERVIEW 196 TABLE 172 XUZHOU KERNEL MEDICAL EQUIPMENT CO., LTD.: COMPANY OVERVIEW 197 TABLE 173 ULTRALITE ENTERPRISES, INC.: COMPANY OVERVIEW 198 TABLE 174 HOENLE MEDICAL GMBH COMPANY OVERVIEW 199 TABLE 175 WEYER GMBH: COMPANY OVERVIEW 199 TABLE 176 SHENZHEN COMEN MEDICAL INSTRUMENTS CO., LTD.: COMPANY OVERVIEW 200 TABLE 177 THERALIGHT, LLC: COMPANY OVERVIEW 201 TABLE 178 ATHRODAX LTD: COMPANY OVERVIEW 202 TABLE 179 CURELIGHT: COMPANY OVERVIEW 203 TABLE 180 PHOTO THERAPEUTICS LTD: COMPANY OVERVIEW 204 TABLE 181 TINY HEARTS TECHNOLOGY: COMPANY OVERVIEW 205 TABLE 182 LIFETRONS INNO EQUIPMENTS PVT LTD: COMPANY OVERVIEW 205 TABLE 183 IBIS MEDICAL EQUIPMENT AND SYSTEMS PVT LTD: COMPANY OVERVIEW 206 TABLE 184 SCI HEALTH: COMPANY OVERVIEW 207 TABLE 185 RISK ASSESSMENT: PHOTOTHERAPY EQUIPMENT 221 FIGURE 1 PHOTOTHERAPY EQUIPMENT MARKET SEGMENTATION 24 FIGURE 2 KEY INSIGHTS AND MARKET HIGHLIGHTS 27 FIGURE 3 PHOTOTHERAPY EQUIPMENT MARKET, 2026–2031 28 FIGURE 4 MAJOR STRATEGIES ADOPTED BY KEY PLAYERS IN PHOTOTHERAPY EQUIPMENT MARKET 29 FIGURE 5 DISRUPTIVE TRENDS IMPACTING GROWTH OF PHOTOTHERAPY EQUIPMENT MARKET 30 FIGURE 6 HIGH-GROWTH SEGMENTS AND EMERGING FRONTIERS IN PHOTOTHERAPY EQUIPMENT MARKET, 2025 31 FIGURE 7 ASIA PACIFIC TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD 32 FIGURE 8 INCREASING ADOPTION OF ENERGY-EFFICIENT LED PHOTOTHERAPY SYSTEMS AND EXPANSION OF HOME-BASED TREATMENT SOLUTIONS TO DRIVE MARKET 33 FIGURE 9 CHINA AND CONVENTIONAL PHOTOTHERAPY EQUIPMENT ACCOUNTED FOR LARGEST MARKET SHARE IN 2025 34 FIGURE 10 INDIA TO REGISTER HIGHEST CAGR DURING FORECAST PERIOD 35 FIGURE 11 NORTH AMERICA ACCOUNTED FOR LARGEST MARKET SHARE IN 2025 35 FIGURE 12 EMERGING ECONOMIES TO REGISTER HIGHER GROWTH RATES DURING FORECAST PERIOD 36 FIGURE 13 PHOTOTHERAPY EQUIPMENT MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 37 FIGURE 14 PHOTOTHERAPY EQUIPMENT MARKET: PORTER’S FIVE FORCES ANALYSIS 49 FIGURE 15 PHOTOTHERAPY EQUIPMENTS MARKET: SUPPLY CHAIN ANALYSIS 54 FIGURE 16 VALUE CHAIN ANALYSIS: MAJOR VALUE ADDED DURING MANUFACTURING AND ASSEMBLY PHASES 56 FIGURE 17 PHOTOTHERAPY EQUIPMENT MARKET: ECOSYSTEM ANALYSIS 57 FIGURE 18 TRENDS/DISRUPTIONS INFLUENCING CUSTOMERS’ BUSINESSES IN PHOTOTHERAPY EQUIPMENT MARKET 62 FIGURE 19 PHOTOTHERAPY EQUIPMENT MARKET: INVESTMENT & FUNDING SCENARIO 62 FIGURE 20 NUMBER OF PATENTS PUBLISHED (JANUARY 2016–MAY 2026) 71 FIGURE 21 TOP APPLICANT COUNTRIES/REGIONS FOR PHOTOTHERAPY EQUIPMENT (JANUARY 2016− MAY 2026) 72 FIGURE 22 INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS OF PHOTOTHERAPY EQUIPMENT 79 FIGURE 23 KEY BUYING CRITERIA FOR PHOTOTHERAPY EQUIPMENT 79 FIGURE 24 NORTH AMERICA: PHOTOTHERAPY EQUIPMENT MARKET SNAPSHOT 107 FIGURE 25 ASIA PACIFIC: PHOTOTHERAPY EQUIPMENT MARKET SNAPSHOT 127 FIGURE 26 REVENUE ANALYSIS OF TOP PLAYERS IN PHOTOTHERAPY EQUIPMENT MARKET, 2021–2025 (USD MILLION) 155 FIGURE 27 MARKET SHARE ANALYSIS OF KEY PLAYERS, 2025 156 FIGURE 28 PHOTOTHERAPY EQUIPMENTS MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2025 158 FIGURE 29 PHOTOTHERAPY EQUIPMENT MARKET: COMPANY FOOTPRINT 159 FIGURE 30 PHOTOTHERAPY EQUIPMENT MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2025 163 FIGURE 31 EV/EBITDA OF KEY VENDORS 166 FIGURE 32 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS 166 FIGURE 33 PHOTOTHERAPY EQUIPMENT MARKET: BRAND COMPARISON 167 FIGURE 34 GE HEALTHCARE: COMPANY SNAPSHOT 172 FIGURE 35 DRÄGERWERK AG & CO. KGAA: COMPANY SNAPSHOT 175 FIGURE 36 RESEARCH DESIGN 208 FIGURE 37 PRIMARY SOURCES 210 FIGURE 38 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY/DEMAND-SIDE PARTICIPANTS 212 FIGURE 39 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE PARTICIPANTS, BY COMPANY TYPE, DESIGNATION, AND REGION 213 FIGURE 40 BREAKDOWN OF PRIMARY INTERVIEWS (DEMAND SIDE): BY END USER, DESIGNATION, AND REGION 213 FIGURE 41 REVENUE SHARE ANALYSIS ILLUSTRATION: GE HEALTHCARE 215 FIGURE 42 SUPPLY-SIDE ANALYSIS OF TOP COMPANIES (2025) 215 FIGURE 43 PHOTOTHERAPY EQUIPMENT MARKET: CAGR PROJECTIONS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES (2024–2031) 217 FIGURE 44 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS 218 FIGURE 45 DATA TRIANGULATION METHODOLOGY

Single User Licence	$4,950 USD
Multi User Licence	$6,650 USD
Corporate User Licence	$8,150 USD
Global User Licence	$10,000 USD

Phototherapy Equipment Market by Product (Conventional Phototherapy Equipment, Fiber-Optic Phototherapy Equipment), Application (Neonatal Jaundice, Skin Diseases (Psoriasis, Vitiligo)), End User (Hospitals, Homecare Settings) - Global Forecast to 2031

授權報價

報告摘要

同分類最新報告（醫療器材）